Lucerne
Switzerland
7
2018-04-12
4
2018-05-15
These are the the leading inventors for applications assigned to ONCOETHIX GMBH:
ONCOETHIX GMBH based in Lucerne, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PHARMACEUTICAL DOSES FOR A BROMODOMAIN AND EXTRATERMINAL PROTEIN (BET) INHIBITOR
#2 | 2017-10-05METHODS OF TREATING ACUTE MYELOID LEUKEMIA OR ACUTE LYMPHOID LEUKEMIA USING PHARMACEUTICAL COMPOSITIONS CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS
#3 | 2017-09-28 ✅ Patent 9,968,620 granted on 2018-05-15Methods of treating lymphoma using thienotriazolodiazepine compounds
#4 | 2017-06-01 ✅ Patent 9,901,583 granted on 2018-02-27Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds
#5 | 2017-04-06METHOD OF TREATING RESISTANT NON-HODGKIN LYMPHOMA, MEDULLOBLASTOMA, AND/OR ALK+NON-SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS
#6 | 2017-03-09 ✅ Patent 9,968,619 granted on 2018-05-15Method of treating triple-negative breast cancer using thienotriazolodiazepine compounds
#7 | 2017-02-23 ✅ Patent 9,956,228 granted on 2018-05-01Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine compounds
Also check out ONCOETHIX GMBH's (Lucerne, Switzerland) applicant profile with 4 patent applications submitted.
119353 ⎘